Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of Erythrocytes01:27

Disorders of Erythrocytes

713
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
713
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

1.8K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
1.8K
Disorders of Hemostasis01:24

Disorders of Hemostasis

633
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
633
Overview of Hematopoiesis01:20

Overview of Hematopoiesis

3.6K
Hematopoiesis, or blood cell production, is a vital biological process that begins early in embryonic development and continues throughout life. This process generates the various types of cells found in blood, including red blood cells, white blood cells, and platelets from hematopoietic stem cells (HSCs).
Developmental Phases of Hematopoiesis
Initially, HSCs are formed in the embryonic yolk sac, a critical site for early blood cell production. These stem cells subsequently migrate to other...
3.6K
Hematopoiesis01:21

Hematopoiesis

4.9K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
4.9K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

1.4K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Comprehensive analysis of FLT3-mutated patients with acute myeloid leukemia with updated 2022 European LeukemiaNet recommendations: insights from the Turkish AML registry project.

BMC cancer·2025
Same author

Long-term Results of Imatinib Discontinuation in Patients with Chronic-phase Chronic Myeloid Leukemia: A National Multicenter Prospective Study

Turkish journal of haematology : official journal of Turkish Society of Haematology·2023
Same author

Comparison of different intravenous iron preparations in terms of total oxidant and total antioxidant status, single center data.

Annals of hematology·2023
Same author

Immune-Mediated Thrombotic Thrombocytopenic Purpura after BNT162b2 Vaccine

Turkish journal of haematology : official journal of Turkish Society of Haematology·2021
Same author

Clinical Characteristics and Outcomes of COVID-19 in Turkish Patients with Hematological Malignancies

Turkish journal of haematology : official journal of Turkish Society of Haematology·2021
Same author

Infections in hematopoietic stem cell transplant patients admitted to Hematology intensive care unit: a single-center study.

Hematology (Amsterdam, Netherlands)·2021

Related Experiment Video

Updated: May 7, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

15.9K

Hematological diseases and the heart.

Ferda Can1

  • 1Division of Hematology, Department of Internal Medicine, Ankara Bilkent City Hospital, Ankara, Turkiye.

Turkish Journal of Medical Sciences
|December 30, 2024
PubMed
Summary
This summary is machine-generated.

Hematological diseases frequently impact the heart, leading to cardiac problems during treatment. Understanding cardiac involvement is crucial for diagnosing and treating patients with blood disorders.

Keywords:
Hematological diseasecardiac involvementheart

More Related Videos

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.2K
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

10.0K

Related Experiment Videos

Last Updated: May 7, 2025

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases
11:08

Endothelialized Microfluidics for Studying Microvascular Interactions in Hematologic Diseases

Published on: June 22, 2012

15.9K
Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis
08:00

Bone Marrow Transplantation Procedures in Mice to Study Clonal Hematopoiesis

Published on: May 26, 2021

12.2K
Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS
08:12

Invasive Hemodynamic Monitoring of Aortic and Pulmonary Artery Hemodynamics in a Large Animal Model of ARDS

Published on: November 26, 2018

10.0K

Area of Science:

  • Cardiology
  • Hematology
  • Internal Medicine

Background:

  • The heart is a primary organ affected by hematological diseases.
  • Cardiac complications can arise during the course and treatment of both benign and malignant hematological conditions.

Purpose of the Study:

  • To summarize cardiac involvement manifestations in hematological diseases.
  • To provide key information for diagnosing and treating cardiac issues in hematology patients.

Main Methods:

  • Literature review of recent scientific information.
  • Synthesis of data on cardiac manifestations in hematological diseases.

Main Results:

  • Hematological diseases significantly affect the heart.
  • Cardiac problems are common during the management of blood disorders.
  • Knowledge of cardiac involvement aids diagnosis and treatment.

Conclusions:

  • Appropriate cardiac approaches are vital for patients with hematological diseases.
  • Understanding pathophysiological cardiac involvement is key.
  • This review offers essential insights for clinical practice.